US Generic Drug Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2018-2023

$ 1499


The US generic drug market has witnessed a transformation over the last three decades. From less than 20% of the total prescriptions, generic drugs now account for the majority of the total prescriptions dispensed in the United States. During 2011-2017, the US generic drug market grew at a CAGR of 13% and currently represents a multibillion dollar industry. The biggest catalyst of this industry is the significantly lower price of generics compared to branded drugs. Although generics are chemically identical to their branded counterparts, they are typically sold at substantial discounts from the branded price. This has enabled governments and third-party payers to save billions of dollars in healthcare expenditures and resulted in lower copayments for patients. Other factors such as patent expiration of blockbuster innovator drugs, ageing population and an increasing prevalence of chronic diseases have also acted as catalysts for this market.

US Generic Drug Market Size

The report entitled “US Generic Drug Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2018-2023” provides a comprehensive insight into the historical and current trends as well as the future prospects of the generic drug market in the United States. This study serves as an exceptional tool to understand the sales trends, volume trends, growth, key segments, competitive structure, regulations, major manufacturer, major distributors, top drugs, manufacturing requirements, opportunities and future prospects of the US generic drug market. This report can serve as an excellent guide for manufacturers, consultants, researchers, marketing strategists and all those who plan to foray into the US generic drug market in any form.

Key Questions Answered in This Report:

  • Historical, current and future sales trends in the US generic drug market?
  • Historical, current and future prescription trends in the US generic drug market?
  • Performance of the US generic drug market compared to the US pharmaceutical market?
  • Performance of the US generic drug market compared to other major generic drug markets?
  • Structure of the US generic drug market?
  • Market Breakup by Therapy Area?
  • Market Breakup by Drug Delivery?
  • Market Breakup by Distribution Channel?
  • Competitive landscape in the US generic drug market?
  • Top US generic drug manufacturers and their market shares?
  • Distribution of generic drugs in the US?
  • Top US generic drug distributors and their market shares?
  • Most prescribed generic drugs in the US?
  • Pricing analysis of generic drugs?
  • Value chain analysis of generic drugs in the US?
  • Regulations in the US generic drug market?
  • Manufacturing process of generic drugs?
  • Machinery and raw material requirements for manufacturing generic drugs?
  • Key success and risk factors in the US generic drug market?

1 Preface
2 Research Methodology and Market Definitions
3 Executive Summary
4 US Generic Drug Market - Introduction

    4.1 What are Generic Drugs?
    4.2 Unbranded and Branded Generics
    4.3 Authorized Generics
    4.4 Commoditized and Specialty Generics
5 Why is the US Generic Drug Market so Lucrative
    5.1 Patent Expiry of Blockbuster Drugs
    5.2 Significant Price Differential between Generics and Innovator Drugs
    5.3 Savings for the Government and Third Party Payers
    5.4 Incentives for Dispensing and Prescribing Generic Drugs
    5.5 Reimbursement and Lower Copayments
    5.6 Biosimilars
6 Global Generic Drug Market
    6.1 Market Performance
        6.1.1    Volume Trends
        6.1.2    Value Trends
    6.2 Market Breakup by Country
    6.3 Market Forecast
    6.4 Most Prescribed Generic and Branded Drugs
7 US Generic Drug Market
    7.1 US Pharmaceutical Market Performance
        7.1.1    Volume Trends
        7.1.2    Value Trends
        7.1.3    Market Breakup by Type
        7.1.4    Market Forecast
    7.2 US Generic Drug Market Performance
        7.2.1    Volume Trends
        7.2.2    Value Trends
        7.2.3    Market Breakup by Segment
        7.2.4    Market Breakup by Therapy Area
        7.2.5    Market Breakup by Drug Delivery
        7.2.6    Market Breakup by Distribution Channel
        7.2.7   Market Forecast
8 US Generic Drug Market - Market Breakup by Segment
    8.1 Unbranded Generics
    8.2 Branded Generics
9 US Generic Drug Market - Market Breakup by Therapy Area
    9.1 CNS
    9.2 Cardiovascular
    9.3 Dermatology
    9.4 Genitourinary/Hormonal 
    9.5 Respiratory
    9.6 Rheumatology 
    9.7 Diabetes
    9.8 Oncology
    9.9 Others
10 Market Breakup By Drug Delivery
    10.1 Oral
    10.2 Injectables   
    10.3 Dermal/Topical
    10.4 Inhalers
11 Market Breakup By Distribution Channel
    11.1 Retail Pharmacies
    11.2 Hospital Pharmacies
12 US Generic Drug Market - SWOT Analysis
    12.1 Strengths
    12.2 Weaknesses
    12.3 Opportunities
    12.4 Threats
13 US Generic Drug Market - Value Chain Analysis
    13.1 Research and Development
    13.2 Manufacturing
    13.3 Marketing and Distribution
14 Pricing Mechanism and Profit Margins at Various Levels of the Supply Chain
15 Porter’s Five Forces Analysis

    15.1 Overview
    15.2 Bargaining Power of Buyers
    15.3 Bargaining Power of Suppliers
    15.4 Degree of Rivalry
    15.5 Threat of New Entrants
    15.6 Threat of Substitutes
16 US Generic Drug Market- Competitive Landscape
    16.1 US Generic Drug Market - Competitive Structure
    16.2 US Generic Drug Market - Breakup of Key Players
    16.4 US Generic Drug Market - Most Prescribed Generic Drugs
    16.5 US Generic Drug Market - Market Breakup by Distribution
    16.6 US Generic Drug Market - Pricing Dynamics
17 Regulations in the US Generic Drug Industry
    17.1 Overview of Pharmaceutical Regulations
    17.2 Drug Applications
    17.3 Patents and Market Exclusivity
    17.4 Regulatory Requirements for Generic Drugs
    17.5 The Hatch-Waxman Act
    17.6 Certifications
    17.7 Other Important Considerations
18 US Generic Drug Market: Key Success Factors
19 US Generic Drug Market: Road Blocks
20 Requirements for Setting Up a Generic Drug Manufacturing Plant

     20.1 Manufacturing Process
     20.2 Raw Material Requirements
     20.3 Raw Materials Pictures
     20.4 Land and Construction Requirements 
     20.5 Machinery and Infrastructure Requirements
     20.6 Machinery Pictures
     20.7 Plant Layout
     20.8 Packaging Requirements 
     20.9 Utility Requirements 
    20.10 Manpower Requirements
21 US Generic Drug Market - Key Company Profiles
    21.1 Teva
    21.2 Mylan
    21.3 Actavis
    21.4 Sandoz
    21.5 Sun Pharma
    21.6 Par Pharmaceuticals
    21.7 Endo Pharmaceuticals
    21.8 Lupin Pharmaceuticals
    21.9 Dr Reddy’s
    21.10 Hospira    

 

List of Figures

Figure 1: Structure of the Pharmaceutical Industry
Figure 2: Classification of Generic Drugs
Figure 3: US: Patent Expiry Exposure (in Billion US$)
Figure 4: US: Savings from Generic Drugs (in Billion US$), 2006-2017
Figure 5: Global: Generic Drug Market: Sales Value (in Billion US$), 2011-2017
Figure 6: Global: Generic Drug Market: Sales Volume (in Billion Standards Units), 2011-2017
Figure 7: Global: Generic Drug Market: Sales Value Breakup by Country (in %), 2017
Figure 8: Global: Generic Drug Market: Sales Volume Breakup by Country (in %), 2017
Figure 9: Global: Generic Drug Market Forecast: Sales Value (in Billion US$), 2018-2023
Figure 10: Global: Generic Drug Market: Sales Volume (in Billion Standards Units), 2018-2023
Figure 11: US: Pharmaceutical Market: Sales Volume (in Million Prescriptions), 2011-2017
Figure 12: US: Pharmaceutical Market: Sales Value (in Billion US$), 2011-2017
Figure 13: US: Pharmaceutical Market Forecast: Sales Value (in Billion US$), 2018-2023
Figure 14: US: Pharmaceutical Market: Sales Volume (in Million Prescriptions), 2018-2023
Figure 15: US: Pharmaceutical Market: Sales Volume Breakup of Branded and Generic Drugs (in %), 2011 and 2017
Figure 16: US: Pharmaceutical Market: Sales Value Breakup of Branded and Generic Drugs (in %), 2011 and 2017
Figure 17: US: Generic Drug Market: Sales Volume (in Million Prescriptions), 2011-2017
Figure 18: US: Generic Drug Market Forecast: Sales Volume (in Million Prescriptions), 2018-2023
Figure 18: US: Generic Drug Market: Sales Value (in Billion US$), 2011-2017
Figure 19: US: Generic Drug Market Forecast: Sales Value (in Billion US$), 2018-2023
Figure 20: US: Generic Drug Market: Market Breakup by Segment (in %), 2011-2017
Figure 21: US: Generic Drug Market: SWOT Analysis
Figure 22: US: Generic Drug Market: Value Chain Analysis
Figure 23: US: Generic Drug Market: Pricing Mechanism and Profit Margins at the Various Levels of the Supply Chain
Figure 24: US: Generic Drug Market: Porter's Five Forces Analysis
Figure 25: US: Generic Drug Market: Orals (in Million US$), 2010, 2017 & 2023
Figure 26: US: Generic Drug Market: Injectables (in Million US$), 2010, 2017 & 2023
Figure 27: US: Generic Drug Market: Dermal/Topical (in Million US$), 2010, 2017 & 2023
Figure 28: US: Generic Drug Market: Inhalers (in Million US$), 2010, 2017 & 2023
Figure 29: US: Generic Drug Market: Retail Pharmacies (in Million US$), 2010, 2017 & 2023
Figure 30: US: Generic Drug Market: Hospital Pharmacies (in Million US$), 2010, 2017 & 2023
Figure 31: US: Generic Drug Market: Sales Share of Top Players (in %), 2017
Figure 32: US: Generic Drug Market: Volume Share of Top Players (in %), 2017
Figure 33: US: Generic Drug Market: Volume Share by Distribution (in %), 2017
Figure 34: US: Generic Drug Prices as a Percentage of Branded Drug Prices – Based on Number of Competitors
Figure 35: US: Generic Drug Market: Detailed Process Flow
Figure 36: US: Generic Drug Market: Raw Material Requirements
Figure 37: US: Generic Drug Market: Plant Layout
Figure 38: US: Generic Drug Market: Packaging Requirements
 
 

List of Tables

Table 1: US: Sales and Patent Expiry of Major Drugs Expected to Lose Patent Protection (in Billion US$)
Table 2: US: Expenses of Generic and Branded Drug Manufacturers (in %)
Table 3: Sales Volume and Growth in Major Markets, 2017
Table 4: Volume Performance of Top Generic Drugs (in Million Prescriptions), 2017
Table 5: Global: Branded Drug Market: Volume Performance of Top Branded Drugs (in Million Prescriptions), 2017
Table 6: US: generic Drug Market: Sales Performance of Top Players (in Billion US$), 2017
Table 7: US: Generic Drug Market: Volume Performance of Top Players (in Billion Units), 2017
Table 8: US: Generics Market: Volume Performance of Top Generic Drugs (in Million Prescriptions), 2017
Table 9: US: Overview of Pharmaceutical Regulations
Table 10: US: Generic Drug Market: Land and Construction Requirements
Table 11: US: Generic Drug Market: Machinery and Infrastructure Requirements
Table 12: US: Generic Drug Market: Utility Requirements
Table 13: US: Generic Drug Market: Manpower Requirements


Note: We value your privacy and will never rent or sell your email address. Privacy policy

Special Prices


    IMARC provides special pricing for:

  • Academic Institutes
  • Government Agencies
  • Nonprofit Organizations
  • For more information, feel free to contact us.